SG11202105231UA - Pharmaceutical composition for treating wounds - Google Patents

Pharmaceutical composition for treating wounds

Info

Publication number
SG11202105231UA
SG11202105231UA SG11202105231UA SG11202105231UA SG11202105231UA SG 11202105231U A SG11202105231U A SG 11202105231UA SG 11202105231U A SG11202105231U A SG 11202105231UA SG 11202105231U A SG11202105231U A SG 11202105231UA SG 11202105231U A SG11202105231U A SG 11202105231UA
Authority
SG
Singapore
Prior art keywords
pharmaceutical composition
treating wounds
wounds
treating
pharmaceutical
Prior art date
Application number
SG11202105231UA
Inventor
Sang Yup Lee
Won Min Yoo
Sooncheol Kim
Hannah Chung
Jiyong Kim
Original Assignee
Medicosbiotech Inc
Korea Advanced Inst Sci & Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicosbiotech Inc, Korea Advanced Inst Sci & Tech filed Critical Medicosbiotech Inc
Publication of SG11202105231UA publication Critical patent/SG11202105231UA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/16Blood plasma; Blood serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
SG11202105231UA 2018-11-23 2019-11-21 Pharmaceutical composition for treating wounds SG11202105231UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020180146287A KR20200060997A (en) 2018-11-23 2018-11-23 Pharmaceutical Composition for Treatment of Wounds
PCT/KR2019/016011 WO2020106074A1 (en) 2018-11-23 2019-11-21 Pharmaceutical composition for treating cuts

Publications (1)

Publication Number Publication Date
SG11202105231UA true SG11202105231UA (en) 2021-06-29

Family

ID=70773904

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202105231UA SG11202105231UA (en) 2018-11-23 2019-11-21 Pharmaceutical composition for treating wounds

Country Status (8)

Country Link
US (1) US20220008463A1 (en)
EP (1) EP3884952A4 (en)
JP (1) JP7309872B2 (en)
KR (1) KR20200060997A (en)
CN (1) CN113194965A (en)
AU (1) AU2019383263B2 (en)
SG (1) SG11202105231UA (en)
WO (1) WO2020106074A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102363366B1 (en) * 2018-11-23 2022-02-16 (주)메디코스바이오텍 Composition for Treating Alopecia or Stimulating Hair Growth

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60245412A (en) 1984-05-18 1985-12-05 株式会社日立製作所 Gas insulated switching device
US4957742A (en) * 1984-11-29 1990-09-18 Regents Of The University Of Minnesota Method for promoting hair growth
FR2649888B1 (en) 1989-07-18 1994-08-26 Exsymol Sa PRODUCTS FOR SKIN APPLICATIONS, WITH COSMETIC OR / AND THERAPEUTIC EFFECTS
US5183805A (en) 1990-08-13 1993-02-02 Board Of Regents, The University Of Texas System Bioactive egf peptides for promotion of tissue regeneration and cancer therapy
US5981606A (en) 1991-03-01 1999-11-09 Warner-Lambert Company Therapeutic TGF-beta-wound healing compositions and methods for preparing and using same
US5149691A (en) 1991-03-12 1992-09-22 Creative Biomolecules, Inc. Issue repair and regeneration through the use of platelet derived growth factor (pdgf) in combination with dexamethasone
GB9225581D0 (en) 1992-12-08 1993-01-27 Courtaulds Plc Wound dressings
US5519020A (en) 1994-10-28 1996-05-21 The University Of Akron Polymeric wound healing accelerators
WO1996030038A1 (en) 1995-03-29 1996-10-03 The Rockefeller University Peptide growth factor having epidermal inducing activity
US5897880A (en) 1995-09-29 1999-04-27 Lam Pharmaceuticals, Llc. Topical drug preparations
CA2315266C (en) 1997-12-12 2004-08-10 University Of Southern California Wound healing compositions
CA2315115C (en) 1998-10-23 2007-03-20 Polyheal Ltd. Compositions of microspheres for wound healing
KR100315168B1 (en) 1999-01-28 2001-11-30 대한민국(관리청:특허청장, 승계청:농촌진흥청장) Preparation of silk fibroin sponge membrane for wound covering materials
JP2005530768A (en) 2002-05-09 2005-10-13 メディジーンズ Pharmaceutical composition for wound treatment containing plasma or serum
KR20070113876A (en) 2006-05-26 2007-11-29 메디제네스(주) A pharmaceutical composition for treatment of wounds containing blood plasma component
KR101317420B1 (en) * 2010-03-11 2013-10-10 한국과학기술원 High Molecular Weight Recombinant Silk or Silk-like Proteins and Micro or Nano-spider Silk or Silk-like Fibres Manufactured by Using the Same
US8986380B2 (en) * 2010-06-09 2015-03-24 Trustees Of Tufts College Multilayered silk scaffolds for meniscus tissue engineering
WO2015048344A2 (en) * 2013-09-27 2015-04-02 Tufts University Silk/platelet composition and use thereof
KR20150061806A (en) * 2013-11-28 2015-06-05 중부대학교 Veterinary composition for wound healing of animal containing activated platelet rich plasma
KR101617075B1 (en) 2014-01-24 2016-04-29 충남대학교산학협력단 Silk fibroin wound dressing materials and manufacturing method thereof
WO2017214631A1 (en) * 2016-06-10 2017-12-14 Liden Brock Systems and methods for treating a wound with a wound packing

Also Published As

Publication number Publication date
AU2019383263A1 (en) 2021-07-08
US20220008463A1 (en) 2022-01-13
KR20200060997A (en) 2020-06-02
EP3884952A1 (en) 2021-09-29
EP3884952A4 (en) 2022-08-03
AU2019383263B2 (en) 2022-09-29
WO2020106074A1 (en) 2020-05-28
JP7309872B2 (en) 2023-07-18
CN113194965A (en) 2021-07-30
JP2022513123A (en) 2022-02-07

Similar Documents

Publication Publication Date Title
PL3431105T3 (en) Medicinal composition for treating cancer
IL280413A (en) Bismuth-thiol compositions and methods for treating wounds
EP3378491A4 (en) Pharmaceutical composition for treatment or prophylaxis of nash
EP3275450A4 (en) Pharmaceutical composition for preventing or treating inflammatory diseases, containinglactococcus chungangensis
ZA201803320B (en) Pharmaceutical compositions for treating pain
EP3329929A4 (en) Pharmaceutical composition for preventing or treating dry eyes
HK1232128A1 (en) Pharmaceutical composition for preventing or treating skin rash
EP3375443A4 (en) Pharmaceutical composition for treating respiratory diseases
IL261774B (en) Compositions for treating dermatological conditions
HK1248130A1 (en) Composition for treating pain
KR101894521B9 (en) Topical pharmaceutical composition for treating scar
IL275525A (en) Pharmaceutical composition for the treatment of cancer
EP3831410A4 (en) Pharmaceutical composition for treating b cell lybphoma
SG11202105231UA (en) Pharmaceutical composition for treating wounds
IL284181A (en) Products for treating bleeding wounds
KR102324922B9 (en) Pharmaceutical composition comprising osteocalcin for preventing or treating inflammatory diseases
KR102316727B9 (en) Pharmaceutical composition for preventing or treating atopic diseases
SG11201913808SA (en) Pharmaceutical composition for preventing or treating osteoarthritis
PL3236961T3 (en) Pharmaceutical composition for preventing or treating cancer
KR102316726B9 (en) Medicinal composition for treating wound
IL289213A (en) Pharmaceutical composition for treating tumor
ZA201805489B (en) Debriding composition for treating wounds
EP3993801A4 (en) Pharmaceutical composition for treating insomnia
EP3782603C0 (en) Pharmaceutical composition for treating gout
GB201814764D0 (en) Pharmaceutical compositions for the treatment of proteinopathies